We know that the current R&D model is broken. By taking a radically different approach, we believe we can solve these problems, together. Syntropy combines the scientific expertise of EMDMerck, with Palantir’s Foundry unique technology, to create a step-change in research and a catalyst for change across the industry. Our business model is unique: Syntropy will never own or seek to own any data. Rather, it provides a platform for collaboration. Syntropy’s core values of security and transparency are powered by an industry leading technology that enables ownership, control and attribution. We create a new way for research institutions to understand their data, while ensuring their chosen biopharmaceutical collaborators get the quality of data they need to bring solutions to patients faster.